These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16223065)

  • 1. Choosing pharmacotherapies for the COMBINE Study--process and procedures: an investigational approach to combination pharmacotherapy for the treatment of alcohol dependence.
    Swift R; Pettinati HM
    J Stud Alcohol Suppl; 2005 Jul; (15):141-7; discussion 140. PubMed ID: 16223065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
    Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field.
    Johnson BA; Ait-Daoud N; Roache JD
    J Stud Alcohol Suppl; 2005 Jul; (15):157-67; discussion 140. PubMed ID: 16223067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for combining acamprosate and naltrexone for treating alcohol dependence.
    Mason BJ
    J Stud Alcohol Suppl; 2005 Jul; (15):148-56; discussion 140. PubMed ID: 16223066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining treatments for alcoholism: why and how?
    Mattson ME; Litten RZ
    J Stud Alcohol Suppl; 2005 Jul; (15):8-16; discussion 6-7. PubMed ID: 16223051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
    Soyka M; Chick J
    Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?
    Doggrell SA
    Expert Opin Pharmacother; 2006 Oct; 7(15):2169-73. PubMed ID: 17020440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.
    Ray LA; Oslin DW
    Drug Alcohol Depend; 2009 Dec; 105(3):256-8. PubMed ID: 19717248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
    Bouza C; Angeles M; Muñoz A; Amate JM
    Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.
    Fucito LM; Park A; Gulliver SB; Mattson ME; Gueorguieva RV; O'Malley SS
    Biol Psychiatry; 2012 Nov; 72(10):832-8. PubMed ID: 22541040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.
    Mason BJ
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):469-75. PubMed ID: 14636963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current pharmacotherapies of alcoholism: a U.S. perspective.
    Anton RF; Swift RM
    Am J Addict; 2003; 12(s1):s53-s68. PubMed ID: 14972780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption.
    Robinson S; Bowe T; Harris AH
    J Subst Abuse Treat; 2013; 45(5):475-7. PubMed ID: 23932227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does family history of alcoholism moderate naltrexone's effects on alcohol use?
    Capone C; Kahler CW; Swift RM; O'Malley SS
    J Stud Alcohol Drugs; 2011 Jan; 72(1):135-40. PubMed ID: 21138720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.
    Kranzler HR; Van Kirk J
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1335-41. PubMed ID: 11584154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.